CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for BL PharmTech Corp (Parent) is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

BL PharmTech Corp (Parent)
193-12, Daeyang-ro, Samseong-myeon
Phone: +82 234014490p:+82 234014490 YONGIN, 16827  South Korea Fax: +82 312992181f:+82 312992181

Business Summary
BL PharmTech Corp, formerly Next BT Co Ltd, is a Korea-based company primarily engaged in the manufacture and sale of health foods. The Company operates its business through four segments. The Health Functional Food Business segment is engaged in the manufacture and sale of products such as red ginsengs, diet foods and vitamins. The Cosmetics Business segment is engaged in the manufacture and sale of anti-aging skincare products and, among others. The Diagnostic and Medical Business segment is engaged in the manufacture and sale of diagnostic kits and other products. The Other segment is engaged in the distribution of health foods and other products.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
12/31/201612/31/2016Yes----

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chief Executive Officer, Director Hyo RimLee 67 3/30/2015 3/30/2015
Internal Auditor Gwang YilLee 55 3/27/2009 3/27/2009
Director Bong NamKim 40 3/29/2013 3/29/2013
3 additional Officers and Directors records available in full report.

General Information
Number of Employees: 11 (As of 9/30/2012)
Outstanding Shares: 88,968,752 (As of 12/31/2021)
Shareholders: 5,350
Fax Number: +82 312992181


Copyright © 2022 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Thursday, September 22, 2022